BRITISH CANNABIS

07/01/2025

🌿 Exciting Times for the Cannabis Industry in 2025 🌍

As highlighted in a recent article by Cannabis Health read it here, 2025 is set to be a pivotal year for the European cannabis sector. At BRITISH CANNABIS, we’re proud to be at the forefront of these transformative efforts, shaping the future of this dynamic industry.

From advocating for greater consumer access to regulatory advancements, to expanding the reach of high-quality CBD and wellness products, our team is fully committed to driving innovation and collaboration. We remain dedicated to ensuring that customers across Europe benefit from the best this industry has to offer.

As we step into the new year, we look forward to strengthening partnerships, embracing new opportunities, and continuing to lead the way with trusted, premium products.

✨ Together, we’re making 2025 a landmark year for cannabis in Europe! ✨

Written by Ben Stevens and Sarah Sinclair. You can read Part 1 here. Growing demand for medical cannabis across Europe Medical cannabis demand across Europe has seen substantial growth, particularly […]

13/12/2024

We’re thrilled to share the latest update about BRITISH CANNABIS™ Medicines, featured in Business of Cannabis! 🗞️

As part of our unwavering commitment to innovation, we’ve shifted our focus toward developing strain-specific sublingual oils. These groundbreaking formulations are set to redefine the landscape of cannabis medicines in the UK, offering patients a more tailored and precise approach to their wellness journeys.

Read the full article here ➡️ https://businessofcannabis.com/british-cannabis-shifts-focus-pioneering-strain-specific-sublingual-oils-in-the-uk/

04/12/2024

We were honoured to welcome eStarCBD Spa last week to our headquarters in Wokingham, Berkshire this November!

It was a pleasure to meet in person and discuss the exciting opportunities ahead as we introduce our high-quality CBD products to the Chilean market. Their visit was invaluable as we strengthened our partnership and explored how BRITISH CANNABIS™ can support the health and well-being of Chileans with our safe, natural products.

We had the opportunity to show them our state-of-the-art facilities, including our laboratories where “the magic is born,” our secure warehouses, and our efficient global distribution opportunities.

We’re proud to be the largest CBD producer in the UK, as recognised by the FSA, and excited about the future as we expand globally. Stay tuned for the next chapter in our journey! | Mantente atento al próximo capítulo de nuestro viaje 🇨🇱

04/11/2024

We were delighted to host the incredible David Haye at British Cannabis HQ last month! It was a fantastic opportunity to connect and discuss all things health and wellness with the boxing legend himself. 🥊

Thank you, David, for stopping by – we’re excited to see what the future holds!

01/11/2024

We’re thrilled to share the highlights of an inspiring meeting between our MD, David Ralson, and esteemed e-StarCBD Natural Pharma distributors in Chile! 🇨🇱🌎

David was warmly welcomed at the Chilean Embassy last week, where he and our partners discussed the next steps in bringing BRITISH CANNABIS to this vibrant new territory.

With our expansion into Chile, we’re not only broadening our global footprint but also bringing premium CBD products to those seeking natural wellness solutions. This partnership with e-StarCBD Spa reflects our commitment to delivering high-quality CBD products that align with Chile’s thriving wellness industry.

Here’s to new horizons and continuing our mission of making trusted CBD accessible worldwide!

18/10/2024

Discover the Benefits of Canndr UK - tap play!

If you’re a doctor or clinic looking to enhance your medical cannabis prescribing process and improve patient care, visit our website to learn more about how Canndr® can support your practice and empower your patients!

👉 Read the full article here: https://lnkd.in/ezRpXWpm
📹 This video was co-created with AI, featuring David

11/10/2024

We are thrilled to announce that our CEO and Founder, Tom Whettem, has been nominated for the Social Impact Award by the Cannabis Industry Council! 

This nomination highlights Tom’s compassionate leadership and the inspiring stories that drive our mission.

Support Tom by casting your vote for this well-deserved recognition! Your voice matters. If you’d like to vote for Tom, click the link in comments!

We are thrilled to announce that our CEO and Founder, Tom Whettem, has been nominated for the Social Impact Award by the Cannabis Industry Council. This recognition not only highlights Tom’s leadership but also underscores the powerful stories that inspire our mission—especially the journey of A...

09/10/2024

🤝 Enhancing Communication and Trust: By bridging the gap between doctors and patients, Canndr UK fosters a collaborative environment, promoting informed discussions and a more personalised approach to care!

Finding the righty medical cannabis treatment can be overwhelming for both doctors and patients. Physicians face challenges such as prescription delays, limited product availability and an ever-changing market.

02/09/2024

From early promise to a period of decline, the UK CBD market has seen it all. But now, the industry is bouncing back stronger than ever, and BRITISH CANNABIS™ is leading the revival!

We’re excited to introduce our new range of strain-specific CBD oils, meticulously crafted to set a new standard in quality, transparency, and effectiveness. Each product is accompanied by detailed lab reports, so you can trust exactly what you’re consuming.

It's time to restore confidence in CBD. Join us in this new era of excellence 🚀

The UK CBD industry has seen its share of ups and downs - from the early days of promise to a period of decline as low-quality products eroded consumer trust. Now, the industry stands on the bring of a resurgence, and BRITISH CANNABIS™ is leading this revival with our new range of strain-specific ...

26/08/2024

Patient safety and product quality are our utmost priorities. All BRITISH CANNABIS Medicines undergo rigorous testing in UK certified laboratories, with each batch accompanied by a Certificate of Analysis (COA). These measures ensure our products are free from external contaminants and accurately dosed, providing confidence in treatment consistency and reliability.

➡️ https://britishcannabis.org/news/british-cannabis-medicines-pioneering-strain-specific-sublingual-oils-for-bespoke-patient-care/

22/08/2024

🌿 Our BRITISH CANNABIS Medicines support a titration model, allowing for gradual dose increases until optimal therapeutic effects are achieved. This method is particularly valuable in managing conditions such as chronic pain, anxiety and epilepsy, where precise dosing can significantly impact outcomes.

Read full article 📖 https://britishcannabis.org/news/british-cannabis-medicines-pioneering-strain-specific-sublingual-oils-for-bespoke-patient-care/

19/08/2024

If you're curious about the benefits of our newly launched strain-specific sublingual oils, check out our latest article!

https://britishcannabis.org/news/british-cannabis-medicines-pioneering-strain-specific-sublingual-oils-for-bespoke-patient-care/

It's a quick read that covers everything from rapid onset to easy use 🌱📖